Kulicke and Soffa Industries Inc (KLIC)
🔔 Watch stock
symbol.quality_heading
The business works in principle, but one material question is open. As long as it stays open, our findings do not carry a quality verdict.
Whoever buys today is betting that the cycle upswing carries at least into fiscal year 2027 and that neither export controls nor the three top customers interfere — and pays 39 times an estimated, not-yet-earned profit for it. Whoever waits may miss further momentum percent, but receives fresh evidence at every quarterly date — the next is scheduled for August 5, 2026: do bookings and ball bonding growth stay double-digit, does gross margin hold the 45 percent zone, and does the China concentration ease? The decision is yours.
symbol.quality_note
Wire-bonder specialist Kulicke & Soffa lights up 31 filters in our in-house stock scanner (momentum run as of July 17, 2026) — a Stan Weinstein stage-2 uptrend, relative strength of 97, almost a four-bagger in twelve months (data as of July 8, 2026). We read the annual reports (10-K) for fiscal years 2023 through 2025 and the quarterly reports (10-Q) through April 4, 2026: a revenue mountain that ran from $1.5 billion down to $654 million, a comeback quarter at plus 49.8 percent, an $86 million walk-away payment from an unnamed mega-customer, three buried business lines, a CFO who doubles as interim CEO — and 54.6 percent of revenue from customers headquartered in China. Not investment advice — just the math on what a flawless uptrend costs when a cyclical has to deliver it.
Read the analysis
Stock Watch
This analysis is as of July 17, 2026. Stock Watch will tell you what's changed at KLIC since then.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 31 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 89.20 $ — 56% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
NeutralGeprüft am 17.07.2026: In den ausgewerteten SEC-Berichten von Kulicke and Soffa Industries (CIK 56978; 4×10-Q bis zum 04.04.2026 plus 10-K für die Geschäftsjahre 2025 und 2024, Geschäftsjahresende Anfang Oktober) findet sich kein wesentlicher KI-Bezug im Sinne des Kriterienkatalogs. Befund: Die 10-Q zum 04.04.2026, 03.01.2026 und 28.06.2025 enthalten keinerlei KI-Treffer. Der 10-Q zum 29.03.2025 nennt „artificial intelligence“ nur regulatorisch — im Abschnitt zu US-Exportkontrollen wird das BIS-„Framework for AI Diffusion“ referiert („a set of additional export controls on advanced computing chips and certain closed artificial intelligence (‚AI‘) model weights“), also fremde Regeln, kein eigenes KI-Geschäft. Die 10-K für die Geschäftsjahre 2025 und 2024 erwähnen KI ausschließlich als Cyber-Boilerplate („artificial intelligence (‚AI‘) may be used to generate cyberattacks with greater scale and efficacy“ bzw. „threat actors may leverage other means and technologies, including artificial intelligence, to circumvent controls and avoid detection“) — generische Angriffsvektor-Floskeln, nach dem Kriterienkatalog kein Bedroht-Beleg. Eine KI-Umsatzquelle (verkauft) oder ein belegter operativer KI-Einsatz (nutzt) findet sich nirgends; dass die Endnachfrage nach Advanced-Packaging-/Memory-Equipment auch von KI-Rechenzentren getrieben sein dürfte, wird in den Filings nicht als eigener KI-Bezug ausgewiesen und bleibt damit außen vor. Nach dem Kriterienkatalog: „neutral“ (dokumentierter Negativ-Befund).
View the full file — quotes, sources, reviewed filings
Filings Reviewed: 10-Q 2026-05-07 · 10-Q 2026-02-05 · 10-Q 2025-08-06 · 10-Q 2025-05-07 · 10-K 2025-11-20 · 10-K 2024-11-14
Rated on July 17, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 12.1% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 09/30/2026 | 3.36 | 3.31 – 3.40 | 1,083 | 1,500.0% | 3 |
| 09/30/2027 | 4.24 | 3.85 – 4.58 | 1,273 | 26.1% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.87 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.51 | 824.10 | 166 | -3.00 | 49.10 | 19 | 9 |
| 2025: Q1 | -1.59 | – | 162 | -5.90 | -52.20 | 80 | 78 |
| 2025: Q2 | -0.06 | -128.40 | 148 | -18.30 | -2.20 | 7 | 5 |
| 2025: Q3 | 0.12 | -44.90 | 178 | -2.10 | 3.60 | 7 | 4 |
| 2025: Q4 | 0.32 | -78.80 | 200 | 20.20 | 8.40 | -9 | -12 |
| 2026: Q1 | 0.66 | – | 243 | 49.80 | 14.50 | 10 | 6 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 627 | 54 | 48 | 0.68 | 68 | 807 | 982 |
| 2017 | 809 | 113 | 126 | 1.75 | 136 | 913 | 1,171 |
| 2018 | 889 | 167 | 57 | 0.80 | 124 | 880 | 1,186 |
| 2019 | 540 | 22 | 12 | 0.18 | 66 | 769 | 1,080 |
| 2020 | 623 | 59 | 52 | 0.83 | 94 | 758 | 1,055 |
| 2021 | 1,518 | 412 | 367 | 5.78 | 300 | 1,095 | 1,602 |
| 2022 | 1,504 | 470 | 434 | 7.09 | 390 | 1,195 | 1,589 |
| 2023 | 742 | 39 | 57 | 0.99 | 173 | 1,175 | 1,500 |
| 2024 | 706 | -93 | -69 | -1.24 | 31 | 944 | 1,240 |
| 2025 | 654 | -3 | 0 | 0.00 | 114 | 821 | 1,104 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Assessment: Opportunities & Risks
Revenue up 49.8 percent to $242.6 million in the second quarter of fiscal year 2026, ball bonding up 141.7 percent, memory revenue up elevenfold; fiscal 2025 bookings up 74 percent, backlog up 65 percent (10-Q as of 04/04/2026, 10-K FY 2025) — the turn comes from the core business.
$487.9 million in cash and investments against zero bank debt, a 72 percent equity ratio, Altman Z around 14; a $0.205 quarterly dividend and a $300 million buyback frame — though the buyback machine effectively stopped in the rally quarter ($0.1 million).
54.6 percent of quarterly revenue from customers headquartered in China, three customers at roughly 39 percent of first-half revenue, Huatian at 29.6 percent of receivables — squarely within the reach of U.S./China export-control policy (10-Q as of 04/04/2026; 10-K FY 2025, Item 1A).
Minus 57 percent of revenue from peak (FY 2021) to trough (FY 2025), fiscal 2025 net income of $213,000 shaped by one-offs in both directions (the $86.2 million walk-away payment, $87.5 million EA wind-down); an EPS rating of 6 out of 99 — the earnings base beneath the rally is young and thin.
CEO retirement effective December 1, 2025; since then CFO Lester Wong has led in a dual role as interim CEO, with the successor search open (10-K FY 2025, Note 18); plus an SEC comment letter of March 2026 about explanation gaps in the numbers work — routine, but no tailwind.
31 hits in the momentum run (as of July 17, 2026), a stage-2 trend, relative strength of 97, about 3 percent below the all-time high — against a forward P/E around 39 (FY 2026 estimates) and a P/S around 9 (data as of July 8, 2026): the market pays for the upswing’s continuation in advance.
Kulicke & Soffa delivers the rare combination of a genuine, core-business-driven cycle turn (quarterly revenue up 49.8 percent, bookings up 74 percent) and a fortress balance sheet with almost half a billion dollars of net cash. Against that stand a price that pre-pays the continuation at 39 times estimated earnings, more than half of revenue with customers headquartered in China, three names as the load-bearing wall of the growth, an open CEO succession — and the certainty, documented in the company’s own annual report, that every aggressive customer investment phase so far has been followed by a phase of excess supply. Not investment advice.
- KLIC reached the research list via the momentum/stage-2 run of our in-house stock scanner on July 17, 2026 (31 hits, including Stan Weinstein stage 2, RS leader ≥90, the Minervini trend template and pros 80 percent) — not via news flow or forum hype.
- Scanner metrics (P/E, P/S, EPS rating, Piotroski, Altman Z) are computed on trailing twelve-month figures; they contain the one-off effects of the restructuring years (Project W reimbursement, EA wind-down) — and, by nature, not a possible further cycle push.
- Price and valuation figures dated July 8, 2026 (about $131.50, roughly $6.9 billion market value); analyses are evergreen, daily prices are not a buy argument. The fiscal year ends in early October — all quarterly references carry the fiscal-year offset.
About the Company
Kulicke and Soffa Industries, Inc. entwirft, fertigt und verkauft Investitionsgüter und Verbrauchsmaterialien in China, den USA, Taiwan, Malaysia, Japan, den Philippinen, Korea, Hongkong und international.
| Employees | 2,551 |
|---|---|
| Headquarters | Singapore, Singapore |
| Address | 23A Serangoon North Avenue 5, 554369 Singapore, Singapore |
| Phone | 65 6880 9600 |
| Website | kns.com |
| IPO Date | 26. Mar 1990 |
| ISIN | US5012421013 |
| Stock Split | 2:1 on 08/01/2000 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Lester A. Wong J.D. | Interim CEO, Executive VP of Finance & IT and CFO | 1966 |
| Robert Nestor Chylak | Senior VP of Central Engineering & CTO | 1959 |
| Mun Pun Wong | Senior Vice President of Global Sales & Supply Chain | 1961 |
| Fusen Ernie Chen Ph.D. | Advisor | 1959 |
| Joseph Elgindy | Senior Director of Investor Relations & Strategic Planning | – |
| Zi Yao Lim | VP of Legal Affairs, General Counsel & Corporate Secretary | 1988 |
| Lisa Lim | Vice President of Global Human Resources | – |
| Meng Kwong HAN | Senior Vice President of Aftermarket Products & Services and Advanced Dispensing Solutions | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 6. Jul 2026 | Dignam Denise | Director | Other | 407 | 0.00 | – |
| 6. Jul 2026 | Yeo Mui Sung | Director | Other | 407 | 0.00 | – |
| 6. Jul 2026 | Kong Peter T M | Director | Other | 407 | 0.00 | – |
| 6. Jul 2026 | Olson Jon A | Director | Other | 407 | 0.00 | – |
| 6. Jul 2026 | Richardson David Jeffrey | Director | Other | 407 | 0.00 | – |
| 6. Jul 2026 | Milzcik Gregory F | Director | Other | 407 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.